Shah PM - Search Results

1

Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.

Shah PM, Maesen FP, Dolmann A, Vetter N, Fiss E, Wesch R. Shah PM, et al. J Antimicrob Chemother. 1999 Apr;43(4):529-39. doi: 10.1093/jac/43.4.529. J Antimicrob Chemother. 1999. PMID: 10350383 Clinical Trial.

2

Serum bactericidal activity of levofloxacin against Streptococcus pneumoniae.

Shah PM. Shah PM. J Antimicrob Chemother. 1999 Jun;43 Suppl C:61-5. doi: 10.1093/jac/43.suppl_3.61. J Antimicrob Chemother. 1999. PMID: 10404340

3

Bactericidal activity of levofloxacin against Streptococcus pneumoniae in an in-vitro model simulating serum pharmacokinetic parameters.

Shah PM, Schwärzel R. Shah PM, et al. J Antimicrob Chemother. 1999 Jun;43 Suppl C:71-5. doi: 10.1093/jac/43.suppl_3.71. J Antimicrob Chemother. 1999. PMID: 10404342

4

The use of levofloxacin in the treatment of respiratory tract infection.

Shah PM. Shah PM. J Chemother. 2000 Oct;12 Suppl 4:27-31. doi: 10.1080/1120009x.2000.11782310. J Chemother. 2000. PMID: 11131957 Review.

5

Comparison of clinical response to cefpirome treatment and minimum inhibitory concentration of causative isolates. Microbiological and Clinical Study Groups.

Shah PM, Schäfer V, Ziemen M, Krauskopf S. Shah PM, et al. J Antimicrob Chemother. 1992 Apr;29 Suppl A:75-80. doi: 10.1093/jac/29.suppl_a.75. J Antimicrob Chemother. 1992. PMID: 1601762

6

In-vitro activity of cefpirome against isolates from patients with urinary tract, lower respiratory tract and wound infections.

Schäfer V, Shah PM, Doerr HW, Ziemen M, Hellwich S, Seibert G. Schäfer V, et al. Among authors: shah pm. J Antimicrob Chemother. 1992 Apr;29 Suppl A:7-12. doi: 10.1093/jac/29.suppl_a.7. J Antimicrob Chemother. 1992. PMID: 1601760

7

Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.

Groll AH, Just-Nuebling G, Kurz M, Mueller C, Nowak-Goettl U, Schwabe D, Shah PM, Kornhuber B. Groll AH, et al. Among authors: shah pm. J Antimicrob Chemother. 1997 Dec;40(6):855-62. doi: 10.1093/jac/40.6.855. J Antimicrob Chemother. 1997. PMID: 9462438 Clinical Trial.

8

Decrease of caffeine elimination in man during co-administration of 4-quinolones.

Stille W, Harder S, Mieke S, Beer C, Shah PM, Frech K, Staib AH. Stille W, et al. Among authors: shah pm. J Antimicrob Chemother. 1987 Nov;20(5):729-34. doi: 10.1093/jac/20.5.729. J Antimicrob Chemother. 1987. PMID: 3480885

9

Bactericidal activity of ceftazidime against Pseudomonas aeruginosa under conditions simulating serum pharmacokinetic.

Shah PM. Shah PM. J Antimicrob Chemother. 1981 Sep;8 Suppl B:135-40. doi: 10.1093/jac/8.suppl_b.135. J Antimicrob Chemother. 1981. PMID: 19802977

10

Fleroxacin: safety, tolerance and effect on the faecal flora of healthy volunteers.

Shah PM, Sammann A, Schäfer V, Seczendi M, Knothe H. Shah PM, et al. J Antimicrob Chemother. 1988 Oct;22 Suppl D:209-13. doi: 10.1093/jac/22.supplement_d.209. J Antimicrob Chemother. 1988. PMID: 3144539

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

728 results

Search Page

Filters